Ovensa's Seed VC Round

Ovensa raised a round of funding on September 12, 2017.

Ovensa is a preclinical stage company that capitalizes on its proprietary TRIOZAN Nanomedicine Delivery Platform, with mucosal and brain-barrier crossing properties, to generate advanced, multi-combin…

Articles about Ovensa's Seed VC Round: